Search
Search Results
##search.searchResults.foundPlural##
-
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2105PDF: 1154HTML: 3677 -
A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 Ophthalmic vein thrombosis following Covid
1229PDF: 428HTML: 377 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3132PDF: 968HTML: 1986 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1173PDF: 548HTML: 2839ATRA induced Reactive Hemophagocytosis: A Case Report: 172 -
-
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1613PDF: 1051HTML: 10685Untitled: 161 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3242PDF: 688HTML: 697Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 163Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 158Table : Distribution of the sites of bleeding and their causes: 163 -
THE CHALLENGE OF AML IN OLDER PATIENTS
2117PDF: 913HTML: 2143 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2285PDF: 880HTML: 478 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1752PDF: 804HTML: 1548 -
Ceftolozane-Tazobatam for febrile neutropenia treatment in hematologic malignancy patients colonized by multi-resistant Enterobacteriaceae: preliminary results from a prospective cohort study Ceftolozane-Tazobatam for febrile neutropenia
7749PDF: 692HTML: 191 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
609PDF: 475HTML: 198 -
GROUP-BASED TRAJECTORY MODELING OF PLATELET IN PATIENTS WITH APLASTIC ANEMIA: A STUDY BASED ON THE MIMIC DATABASE
925PDF: 932Suppl. Files: 612HTML: 91 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1519PDF: 843HTML: 3143Figure 5: 143Figure 4: 140Figure 3: 171Figure 1: 155Figure 2: 145 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1640PDF: 776HTML: 921cover letter: 246 -
The COVID-19 in Omani children with chronic Hemato-oncology diseases COVID-19 in Omani children with chronic Hemato-oncology diseases
759PDF: 658HTML: 290 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1343PDF: 709HTML: 190 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
7799PDF: 3165HTML: 1169 -
NEW STRATEGIES FOR STEM CELL MOBILIZATION
2322PDF: 818HTML: 2437 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1148PDF: 915HTML: 188 -
SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib
896PDF: 483HTML: 169 -
-
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1755PDF: 687HTML: 2082Untitled: 188Untitled: 137Untitled: 151Untitled: 138Untitled: 144Untitled: 160Untitled: 167 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3510PDF: 1075HTML: 23314 -
CHILDREN IN CORONAVIRUSES’ WONDERLAND: WHAT CLINICIANS NEED TO KNOW Corona virus and Children
1340PDF: 901HTML: 284







